13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000884300
Total reported value
$127.2M
$127.2M
83 檔
23.4%
In Q2 2025, Perkins Capital Management Inc's U.S. equity holdings reached a combined market value of $127.2M, distributed across 83 disclosed stock positions.
In Q2 2025, Perkins Capital Management Inc adopted a defensive or profit-taking posture, trimming 28 positions and completely liquidating 4 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | Stock-Healthcare | 7.77% | +0.37% | -8.18% | |
| 2 | LLY | Eli Lilly & Co | Stock-Healthcare | 7.46% | +0.58% | -2.81% | |
| 3 | MSFT | Microsoft CORP | Stock-Tech | 6.14% | -0.68% | -0.81% | |
| 4 | IDXX | Idexx Laboratories Inc | Stock-Healthcare | 5.23% | -1.09% | — | |
| 5 | MGNI | Magnite Inc | Stock-Other | 3.28% | +0.14% | -6.89% | |
| 6 | INUV | Inuvo Inc | Stock-Other | 3.22% | -0.62% | — | |
| 7 | ✓ | Mdxhealth SA | Stock-Other | 3.16% | -2.72% | +20.19% | |
| 8 | ABT | Abbott Laboratories | Stock-Healthcare | 2.97% | -0.54% | -2.63% | |
| 9 | AMD | Advanced Micro Devices | Stock-Tech | 2.75% | +3.39% | -7.21% | |
| 10 | AXGN | Axogen Inc | Stock-Other | 2.60% | +0.13% | -5.84% | |
| 11 | LMAT | Lemaitre Vascular Inc | Stock-Other | 2.56% | -0.73% | -5.17% | |
| 12 | BKSY | Blacksky Technology Inc | Stock-Other | 2.51% | -0.05% | — | |
| 13 | OOMA | Ooma Inc | Stock-Other | 2.47% | +0.21% | -0.20% | |
| 14 | APPS | Digital Turbine Inc | Stock-Other | 2.33% | — | +1.29% | |
| 15 | ELUT | Elutia Inc | Stock-Other | 2.30% | -0.44% | +1.55% | |
| 16 | VCYT | Veracyte Inc | Stock-Other | 2.23% | +0.50% | -5.31% | |
| 17 | TELA | Tela Bio Inc | Stock-Other | 1.71% | -0.01% | -3.82% | |
| 18 | PSNL | Personalis Inc | Stock-Other | 1.67% | +1.09% | -1.87% | |
| 19 | XGN | Exagen Inc | Stock-Other | 1.63% | +0.01% | -45.18% | |
| 20 | BLZE | Backblaze Inc-a | Stock-Other | 1.58% | +2.75% | — | |
| 21 | USIO | Usio Inc | Stock-Other | 1.53% | +0.62% | -0.40% | |
| 22 | ONDS | Ondas Inc | Stock-Tech | 1.44% | -0.40% | — | |
| 23 | PERI | Perion Network Ltd. | Stock-Other | 1.31% | -0.21% | +132.06% | |
| 24 | CYRX | Cryoport Inc | Stock-Other | 1.28% | +0.89% | +6.75% | |
| 25 | QUIK | Quicklogic CORP | Stock-Other | 1.26% | +1.35% | — | |
| 26 | NEO | Neogenomics Inc | Stock-Healthcare | 1.23% | +0.34% | -6.46% | |
| 27 | VCEL | Vericel CORP | Stock-Other | 1.12% | -0.32% | EXIT | |
| 28 | ABBV | Abbvie Inc | Stock-Healthcare | 1.10% | -0.04% | -5.43% | |
| 29 | INGN | Inogen Inc | Stock-Other | 1.05% | -1.16% | EXIT | |
| 30 | CXDO | Crexendo Inc | Stock-Other | 1.04% | +0.12% | — | |
| 31 | ✓ | Stock-Other | 1.02% | -1.07% | EXIT | ||
| 32 | LFVN | Lifevantage CORP | Stock-Other | 0.99% | +0.06% | — | |
| 33 | PFE | Pfizer Inc | Stock-Healthcare | 0.99% | -0.30% | -0.92% | |
| 34 | AAPL | Apple Inc | Stock-Tech | 0.96% | -0.03% | — | |
| 35 | ATRC | Atricure Inc | Stock-Other | 0.96% | -0.31% | -2.67% | |
| 36 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.93% | -0.22% | -19.36% | |
| 37 | SKYT | Skywater Technology Inc | Stock-Other | 0.90% | -0.35% | -12.47% | |
| 38 | T | At&t Inc | Stock-Comm Services | 0.88% | -0.17% | -3.96% | |
| 39 | CIEN | Ciena CORP | Stock-Tech | 0.79% | -0.80% | -31.80% | |
| 40 | CDXS | Codexis Inc | Stock-Other | 0.77% | +0.13% | -2.13% | |
| 41 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.70% | -0.11% | -16.67% | |
| 42 | BFLY | Butterfly Network Inc | Stock-Other | 0.59% | +2.23% | +7.37% | |
| 43 | USB | US Bancorp | Stock-Financials | 0.59% | -0.02% | -1.51% | |
| 44 | CSTL | Castle Biosciences Inc | Stock-Other | 0.57% | -0.05% | -17.58% | |
| 45 | ANIP | Ani Pharmaceuticals Inc | Stock-Other | 0.55% | -0.57% | EXIT | |
| 46 | OPRX | Optimizerx CORP | Stock-Other | 0.53% | -0.02% | -10.32% | |
| 47 | VZ | Verizon Communications Inc | Stock-Comm Services | 0.51% | -0.13% | — | |
| 48 | APYX | Apyx Medical CORP | Stock-Other | 0.51% | — | +10.46% | |
| 49 | VTRS | Viatris Inc | Stock-Healthcare | 0.51% | -0.03% | -5.01% | |
| 50 | NXPI | NXP Semiconductors N.V. | Stock-Tech | 0.51% | +0.05% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | INUV | Inuvo Inc | +3.2% | NEW | New buy |
| 2 | MGNI | Magnite Inc | +1.5% | -6.89% | Trim |
| 3 | BKSY | Blacksky Technology Inc | +1.5% | — | Unchanged |
| 4 | ONDS | Ondas Inc | +1.4% | NEW | New buy |
| 5 | ✓ | Mdxhealth SA | +1.4% | +20.19% | Add |
| 6 | MSFT | Microsoft CORP | +1.2% | -0.81% | Trim |
| 7 | APPS | Digital Turbine Inc | +1.2% | +1.29% | Add |
| 8 | INGN | Inogen Inc | +1.1% | NEW | New buy |
| 9 | ✓ | +1% | NEW | New buy | |
| 10 | IDXX | Idexx Laboratories Inc | +0.9% | — | Unchanged |
| 11 | PERI | Perion Network Ltd. | +0.8% | +132.06% | Add |
| 12 | PSNL | Personalis Inc | +0.7% | -1.87% | Trim |
| 13 | TELA | Tela Bio Inc | +0.5% | -3.82% | Trim |
| 14 | AMD | Advanced Micro Devices | +0.5% | -7.21% | Trim |
| 15 | NTRA | Natera Inc | +0.3% | -8.18% | Trim |
| 16 | CYRX | Cryoport Inc | +0.3% | +6.75% | Add |
| 17 | APYX | Apyx Medical CORP | +0.2% | +10.46% | Add |
| 18 | QUIK | Quicklogic CORP | +0.2% | — | Unchanged |
| 19 | CXDO | Crexendo Inc | +0.2% | — | Unchanged |
| 20 | BLZE | Backblaze Inc-a | +0.1% | — | Unchanged |
| 21 | OPRX | Optimizerx CORP | +0.1% | -10.32% | Trim |
| 22 | SKYT | Skywater Technology Inc | +0.1% | -12.47% | Trim |
| 23 | AIRG | Airgain Inc | -0.1% | — | Unchanged |
| 24 | CSTL | Castle Biosciences Inc | -0.2% | -17.58% | Trim |
| 25 | LFVN | Lifevantage CORP | -0.2% | — | Unchanged |
| 26 | BAX | Baxter International Inc | -0.2% | -36.11% | Trim |
| 27 | DCI | Donaldson Co Inc | -0.2% | -36.23% | Trim |
| 28 | SERA | Sera Prognostics Inc-a | -0.2% | -12.67% | Trim |
| 29 | XOM | Exxon Mobil CORP | -0.2% | EXIT | Sold out |
| 30 | TCMD | Tactile Systems Technology I | -0.2% | -52.74% | Trim |
| 31 | MYO | Myomo Inc | -0.3% | — | Trim |
| 32 | COP | Conocophillips | -0.3% | -19.23% | Trim |
| 33 | GIS | General Mills Inc | -0.3% | -22.27% | Trim |
| 34 | ABBV | Abbvie Inc | -0.3% | -5.43% | Trim |
| 35 | MRK | Merck & Co. Inc. | -0.3% | -16.67% | Trim |
| 36 | GILD | Gilead Sciences Inc | -0.3% | -19.36% | Trim |
| 37 | LMAT | Lemaitre Vascular Inc | -0.3% | -5.17% | Trim |
| 38 | BMY | Bristol-myers Squibb Co | -0.3% | -18.07% | Trim |
| 39 | FAST | Fastenal Co | -0.4% | -12.79% | Trim |
| 40 | HAIN | Hain Celestial Group Inc | -0.4% | -7.40% | Trim |
| 41 | ✓ | Biodesix Inc | -0.4% | — | Unchanged |
| 42 | VCYT | Veracyte Inc | -0.5% | -5.31% | Trim |
| 43 | NEO | Neogenomics Inc | -0.6% | -6.46% | Trim |
| 44 | ELUT | Elutia Inc | -0.7% | +1.55% | Add |
| 45 | VFF | Village Farms International | -0.8% | EXIT | Sold out |
| 46 | LLY | Eli Lilly & Co | -1.1% | -2.81% | Trim |
| 47 | ATEC | Alphatec Holdings Inc | -1.9% | -0.39% | Trim |
| 48 | UTE0 | Cantaloupe Inc | -2% | EXIT | Sold out |
| 49 | AXGN | Axogen Inc | -2.4% | -5.84% | Trim |
| 50 | INUVGBP | Inuvo Inc | -2.6% | EXIT | Sold out |
According to official SEC Form 13F filings, Perkins Capital Management Inc reported a total U.S. public equity portfolio value of $127.2M across 83 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NTRA, LLY, MSFT) accounted for 23.4% of total reported equity market value during Q2 2025.
Top New Position Initiated
INUV
市值: $3.2M
Top Position Liquidated / Trimmed
INUVGBP
前期市值: $2.5M
During Q2 2025, Perkins Capital Management Inc's top holdings by market value included NTRA (7.8%)、LLY (7.5%)、MSFT (6.1%). The largest single position, NTRA, represented 7.8% of total portfolio value.
In Q2 2025, Perkins Capital Management Inc made 42 total portfolio adjustments, initiating 4 new buys, adding to 6 positions, trimming 28 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.